These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 5815693

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Irreversible enzyme inhibitors. CLXI. Proteolytic enzymes. 13. Inhibitors of guinea pig complement derived by quaternization of 3-acylamidopyridines with alpha-bromomethylbenzenesulfonyl fluorides. II.
    Baker BR, Hurlbut JA.
    J Med Chem; 1969 Sep; 12(5):902-5. PubMed ID: 5812209
    [No Abstract] [Full Text] [Related]

  • 3. Irreversible enzyme inhibitors. 183. Proteolytic enzymes. 18. Inhibitors of guinea pig complement derived by quaternization of phenylalkylpyridines with -bromomethylbenzenesulfonyl fluorides.
    Baker BR, Doll MH.
    J Med Chem; 1971 Sep; 14(9):793-9. PubMed ID: 5168671
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of the haemolytic complement activity by derivatives of benzamidine.
    Hauptmann J, Markwardt F.
    Biochem Pharmacol; 1977 Feb 15; 26(4):325-9. PubMed ID: 849323
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of guinea pig complement by aromaticamidine and guanidine compounds.
    Bing DH.
    J Immunol; 1970 Nov 15; 105(5):1289-91. PubMed ID: 5489072
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibitory effects of omega-amino and omego-guanidino acid esters on the first component of human complement.
    Muramatu M, Shiraishi S, Fujii S.
    Biochim Biophys Acta; 1972 Nov 28; 285(1):224-34. PubMed ID: 4675901
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Irreversible enzyme inhibitors. 53. Proteolytic enzymes. XI. Inhibition of guinea pig complement by substituted phenoxyacetamides.
    Baker BR, Hurlbut JA.
    J Med Chem; 1969 May 28; 12(3):415-9. PubMed ID: 5788156
    [No Abstract] [Full Text] [Related]

  • 16. The third component of the guinea pig complement system. 3. Effect of inhibitors.
    Shin HS, Mayer MM.
    Biochemistry; 1968 Aug 28; 7(8):3003-6. PubMed ID: 5666767
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Irreversible enzyme inhibitors. 186. Irreversible inhibitors of the C'la component of complement derived from m-(phenoxypropoxy)benzamidine by bridging to a terminal sulfonyl fluoride.
    Baker BR, Cory M.
    J Med Chem; 1971 Sep 28; 14(9):805-8. PubMed ID: 5140007
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.